Explore

Trendline Trendline
Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical Industries

Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical Industries

Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical Industries
Trendline Trendline
Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Earnings Call Amid Acquisition by Sun Pharmaceutical
Trendline Trendline
Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical
Trendline Trendline
Grant Thornton's Australian Partners to Vote on $800 Million Sale to US-Backed Platform

Grant Thornton's Australian Partners to Vote on $800 Million Sale to US-Backed Platform

Grant Thornton's Australian Partners to Vote on $800 Million Sale to US-Backed Platform
Trendline Trendline
Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options
Trendline Trendline
Stellantis Reports Q1 2026 Financial Results with 6% Revenue Increase

Stellantis Reports Q1 2026 Financial Results with 6% Revenue Increase

Stellantis Reports Q1 2026 Financial Results with 6% Revenue Increase
Trendline Trendline
Federal Signal's SEC Filings Reveal Growth and Strategic Acquisitions

Federal Signal's SEC Filings Reveal Growth and Strategic Acquisitions

Federal Signal's SEC Filings Reveal Growth and Strategic Acquisitions
Trendline Trendline
Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance

Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance

Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance
Trendline Trendline
Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges

Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges

Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges
Trendline Trendline
Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call
Trendline Trendline
Sun Pharma Acquires Organon for $11.75 Billion to Expand Biosimilar and Women's Health Portfolio

Sun Pharma Acquires Organon for $11.75 Billion to Expand Biosimilar and Women's Health Portfolio

Sun Pharma Acquires Organon for $11.75 Billion to Expand Biosimilar and Women's Health Portfolio
Trendline Trendline
Sun Pharma Acquires Organon to Expand Women's Health Portfolio

Sun Pharma Acquires Organon to Expand Women's Health Portfolio

Sun Pharma Acquires Organon to Expand Women's Health Portfolio